‘My retirement is going to be a disaster’: I’m 59 and have $45,000 in my 401(k). I earn $72,000. Am I doomed?
“My student loans are burying me.” Source link
Stock Market
1 Canadian Stock Ready to Surge in 2025 and Beyond
Despite the robust strength in the TSX Index over the past year or so, numerous Canadian stocks are trading at pretty decent multiples. Many of the names, I think, have strong fundamentals and could punch well above their weight class in this new year and going into 2026. Of course, 2025 is sure to be
1 Canadian Stock Ready to Surge in 2025 and Beyond Read More »
Why Is Europe So Obsessed With Green Hydrogen?
Sign up for daily news updates from CleanTechnica on email. Or follow us on Google News! The green hydrogen market has seen plenty of stumbles ever since innovators, investors, and governments began exploring the idea of deploying renewable electricity to push hydrogen gas from water instead of extracting it from natural gas or
Why Is Europe So Obsessed With Green Hydrogen? Read More »
Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate
NEWTON, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced the initiation of two Phase 2, single-arm investigator-sponsored trials evaluating ACER-801 (osanetant) in men with adenocarcinoma of
Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care By Investing.com
ROANOKE, Va. and FRANKLIN LAKES, N.J., Jan. 22, 2025 /PRNewswire/ — Carilion Clinic, a not-for-profit health care organization serving more than 1 million people in Virginia, in partnership with BD, (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Carilion is the first health system in the state and
NZ inflation data signals RBNZ rate cut likely
Tuesday’s release of New Zealand’s consumer price index (CPI) data for the fourth quarter of 2024 showed that underlying inflation continues to soften, aligning with expectations and potentially setting the stage for a rate cut by the Reserve Bank of New Zealand (RBNZ). The reported 0.5% quarter-on-quarter increase in consumer prices matched the forecasts of
NZ inflation data signals RBNZ rate cut likely Read More »
J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat
Medtech and drug company’s 2025 sales guidance is below consensus Source link
J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat Read More »
Is Fortis Stock a Buy Below $62?
Image source: Getty Images Fortis (TSX:FTS) gave up some of its 2024 gains over the past two months. Investors who missed the rally in the second half of last year are wondering if FTS stock is now undervalued and good to buy for a self-directed Tax-Free Savings Account (TFSA) or Registered Retirement Savings Plan (RRSP)
Is Fortis Stock a Buy Below $62? Read More »
Fossil Fuels Advertising Banned In The Hague, Netherlands
Sign up for daily news updates from CleanTechnica on email. Or follow us on Google News! A ban on fossil advertising in the Hague went into effect in January 2025. The city council approved the ban in September 2024. The Hague is the first city in the world to implement such a ban,
Fossil Fuels Advertising Banned In The Hague, Netherlands Read More »
Bellerophon Therapeutics Announces License Agreement for the Commercialization of INOpulse® in Greater China with Baylor BioSciences
WARREN, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that it has entered into a license agreement for the development and commercialization of INOpulse® with Baylor BioSciences, a life sciences company dedicated to the